{"id":"https://openalex.org/W7225660548","doi":"https://doi.org/10.22541/authorea.15011837/v1","title":"Risk of Diabetes Mellitus Associated with Newer vs. Traditional Atypical Antipsychotics in Patients with Psychiatric Disorders: A Pharmacovigilance Analysis of FAERS Data","display_name":"Risk of Diabetes Mellitus Associated with Newer vs. Traditional Atypical Antipsychotics in Patients with Psychiatric Disorders: A Pharmacovigilance Analysis of FAERS Data","publication_year":2026,"publication_date":"2026-11-08","ids":{"openalex":"https://openalex.org/W7225660548","doi":"https://doi.org/10.22541/authorea.15011837/v1"},"language":"en","primary_location":{"id":"doi:10.22541/authorea.15011837/v1","doi":"https://doi.org/10.22541/authorea.15011837/v1","is_oa":true,"landing_page_url":"https://doi.org/10.22541/authorea.15011837/v1","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/authorea.15011837/v1","source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.authorea.com/doi/pdf/10.22541/authorea.15011837/v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023789583","display_name":"Mohammed A. Alabdulwahed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4626487","display_name":"King Faisal University","ror":"https://ror.org/00dn43547","country_code":"SA","type":"education","lineage":["https://openalex.org/I4626487"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Mohammed Alabdulwahed","raw_affiliation_strings":["Department of Clinical Pharmacy, King Faisal University, College of Pharmacy, Alahsa, Eastern Province, KSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, King Faisal University, College of Pharmacy, Alahsa, Eastern Province, KSA","institution_ids":["https://openalex.org/I4626487"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023789583"],"corresponding_institution_ids":["https://openalex.org/I4626487"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.025800000876188278,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9900000095367432},{"id":"https://openalex.org/keywords/newer-antipsychotics","display_name":"newer antipsychotics","score":0.8019999861717224},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8579999804496765},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.6899999976158142},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.7730000019073486},{"id":"https://openalex.org/keywords/reporting-odds-ratio","display_name":"reporting odds ratio","score":0.8040000200271606},{"id":"https://openalex.org/keywords/paliperidone","display_name":"paliperidone","score":0.8190000057220459},{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/asenapine","display_name":"asenapine","score":0.9779999852180481},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":1.0},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.7879999876022339},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.7089999914169312},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9160000085830688},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9210000038146973},{"id":"https://openalex.org/keywords/cariprazine","display_name":"cariprazine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/lumateperone","display_name":"lumateperone","score":0.9760000109672546},{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":0.9750000238418579},{"id":"https://openalex.org/keywords/mental-disorders","display_name":"mental illness","score":0.6320000290870667},{"id":"https://openalex.org/keywords/metabolic-side-effects","display_name":"metabolic side effects","score":0.5720000267028809},{"id":"https://openalex.org/keywords/histamine-h1-receptor-antagonism","display_name":"H1 receptor antagonism","score":0.6309999823570251}],"concepts":[{"id":"https://openalex.org/C2779626651","wikidata":"https://www.wikidata.org/wiki/Q416545","display_name":"Asenapine","level":4,"score":0.9394000172615051},{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.8493000268936157},{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.8375999927520752},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.781000018119812},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7739999890327454},{"id":"https://openalex.org/C2778999636","wikidata":"https://www.wikidata.org/wiki/Q418785","display_name":"Amisulpride","level":4,"score":0.7148000001907349},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.6926000118255615},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.6078000068664551},{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.5940999984741211},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.570900022983551},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.536899983882904},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5281999707221985},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.5253999829292297},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5081999897956848},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.48730000853538513},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.4300000071525574},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.42149999737739563},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40709999203681946},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4027000069618225},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.39989998936653137},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.3758000135421753},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.3230000138282776},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.32199999690055847},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2777000069618225},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.26919999718666077},{"id":"https://openalex.org/C2908997079","wikidata":"https://www.wikidata.org/wiki/Q27157250","display_name":"Paliperidone Palmitate","level":4,"score":0.2621000111103058},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.2522999942302704}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22541/authorea.15011837/v1","doi":"https://doi.org/10.22541/authorea.15011837/v1","is_oa":true,"landing_page_url":"https://doi.org/10.22541/authorea.15011837/v1","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/authorea.15011837/v1","source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.22541/authorea.15011837/v1","doi":"https://doi.org/10.22541/authorea.15011837/v1","is_oa":true,"landing_page_url":"https://doi.org/10.22541/authorea.15011837/v1","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/authorea.15011837/v1","source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225660548.pdf","grobid_xml":"https://content.openalex.org/works/W7225660548.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1524926404","https://openalex.org/W1584182128","https://openalex.org/W1603664273","https://openalex.org/W1969714399","https://openalex.org/W1973549001","https://openalex.org/W1976520993","https://openalex.org/W1979423827","https://openalex.org/W1987216800","https://openalex.org/W2009832071","https://openalex.org/W2014026290","https://openalex.org/W2018491521","https://openalex.org/W2021186654","https://openalex.org/W2029343515","https://openalex.org/W2037081441","https://openalex.org/W2037540688","https://openalex.org/W2043246282","https://openalex.org/W2051386775","https://openalex.org/W2070166018","https://openalex.org/W2074289946","https://openalex.org/W2077827541","https://openalex.org/W2094980364","https://openalex.org/W2109105647","https://openalex.org/W2120893202","https://openalex.org/W2124201657","https://openalex.org/W2127872656","https://openalex.org/W2159155203","https://openalex.org/W2167715051","https://openalex.org/W2321258727","https://openalex.org/W2461679358","https://openalex.org/W2536736867","https://openalex.org/W2613459819","https://openalex.org/W2623772785","https://openalex.org/W2810590812","https://openalex.org/W2982167270","https://openalex.org/W2982685163","https://openalex.org/W3207791644","https://openalex.org/W4230159336","https://openalex.org/W4232541108","https://openalex.org/W4242811026","https://openalex.org/W4378172514","https://openalex.org/W4396696202"],"related_works":["https://openalex.org/W100441917","https://openalex.org/W2139705794","https://openalex.org/W2160525698","https://openalex.org/W2089272346","https://openalex.org/W2116787956","https://openalex.org/W2040738795","https://openalex.org/W2119926858","https://openalex.org/W2084825241","https://openalex.org/W2109105647","https://openalex.org/W81079961"],"abstract_inverted_index":{"Background":[0],"Antipsychotic-induced":[1],"diabetes":[2,37,49,118,210],"mellitus":[3,119],"(DM)":[4],"is":[5],"a":[6,99,130,135],"major":[7,17],"metabolic":[8,28,203,213,248],"complication":[9],"of":[10,39,65],"schizophrenia,":[11],"schizoaffective":[12],"disorder,":[13,15],"bipolar":[14],"and":[16,62,85,89,154,166,174,190,207,222,234,239],"depressive":[18],"disorder.":[19],"1\u2013":[20],"3":[21],"Despite":[22],"efforts":[23],"since":[24],"2006":[25],"to":[26,231],"improve":[27],"tolerability,":[29],"contemporary":[30],"pharmacovigilance":[31],"data":[32],"have":[33,224],"not":[34,247],"assessed":[35],"comparative":[36],"risks":[38],"atypical":[40],"antipsychotics":[41,54],"across":[42,52],"these":[43],"populations.":[44],"Objective":[45],"This":[46],"study":[47],"compares":[48],"disproportionality":[50],"signals":[51,107,242],"13":[53,122],"in":[55],"patients":[56],"with":[57,82],"psychiatric":[58],"disorders,":[59],"using":[60],"crude":[61],"adjusted":[63,171,227],"analyses":[64],"198,336":[66,115],"FAERS":[67,74],"reports":[68],"through":[69],"Q3":[70],"2024.":[71],"Methods":[72],"Retrospective":[73],"analysis.":[75],"Reporting":[76],"odds":[77],"ratios":[78],"(RORs)":[79],"were":[80],"calculated":[81],"2\u00d72":[83],"tables":[84],"within-class":[86],"comparators;":[87],"age-":[88],"sex-adjusted":[90],"RORs":[91],"(aRORs)":[92],"used":[93],"multivariable":[94],"logistic":[95],"regression.":[96],"Signals":[97],"required":[98,109],"lower":[100],"95%":[101],"confidence":[102],"interval":[103],"(CI)":[104],">1.0;":[105],"strong":[106,131],"also":[108],"an":[110],"estimate":[111],">2.0.":[112],"Results":[113],"Among":[114,218],"reports,":[116],"1,651":[117],"events":[120],"involved":[121],"antipsychotics.":[123],"Of":[124],"post-2006":[125],"agents,":[126,220],"only":[127,142],"paliperidone":[128],"showed":[129,134,195],"signal.":[132],"Lurasidone":[133],"sensitive":[136],"signal,":[137],"reaching":[138],"the":[139,169,225],"robust":[140],"threshold":[141],"after":[143],"demographic":[144],"adjustment.":[145],"Brexpiprazole":[146],"(aROR":[147,151,156,187,192],"=":[148,152,157,184,188,193],"0.33),":[149],"lumateperone":[150],"0.61),":[153],"cariprazine":[155],"0.69)":[158],"had":[159,168,176],"low,":[160],"nonsignificant":[161],"signals.":[162,172,180],"Traditional":[163],"agents":[164],"asenapine":[165,221],"ziprasidone":[167,223],"strongest":[170,226],"Olanzapine":[173],"aripiprazole":[175],"significant":[177],"but":[178],"sub-threshold":[179],"Clozapine":[181,238],"(crude":[182],"ROR":[183],"0.50),":[185],"quetiapine":[186],"0.67),":[189],"risperidone":[191],"0.61)":[194],"protective-direction":[196],"signals,":[197,211,228],"reflecting":[198],"reporting":[199],"bias":[200],"rather":[201],"than":[202],"safety.":[204,249],"Conclusions":[205],"Paliperidone":[206],"lurasidone":[208],"show":[209],"warranting":[212],"monitoring":[214],"like":[215],"high-risk":[216],"agents.":[217],"traditional":[219],"likely":[229],"due":[230],"H1":[232],"antagonism":[233],"channeling":[235],"bias,":[236],"respectively.":[237],"olanzapine\u2019s":[240],"protective":[241],"may":[243],"reflect":[244],"Weber-effect":[245],"masking,":[246]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}